This analysis revealed that reduced expression of RSK1 but not RSK2 (Figure 5H and I), and reduced expression of MSK2 but not MSK1 (6F and G) was associated with poor RFS of basal-like breast cancer patients. Here, RPS6KA3 is linked to breast cancer.